|
US3598122A
(en)
|
1969-04-01 |
1971-08-10 |
Alza Corp |
Bandage for administering drugs
|
|
US4144317A
(en)
|
1975-05-30 |
1979-03-13 |
Alza Corporation |
Device consisting of copolymer having acetoxy groups for delivering drugs
|
|
US4262003A
(en)
|
1975-12-08 |
1981-04-14 |
Alza Corporation |
Method and therapeutic system for administering scopolamine transdermally
|
|
US4201211A
(en)
|
1977-07-12 |
1980-05-06 |
Alza Corporation |
Therapeutic system for administering clonidine transdermally
|
|
US4338457A
(en)
|
1980-02-28 |
1982-07-06 |
The Upjohn Company |
Composition and process
|
|
US4525586A
(en)
|
1980-02-28 |
1985-06-25 |
The Upjohn Company |
Composition and process
|
|
US4306075A
(en)
|
1980-03-28 |
1981-12-15 |
The Upjohn Company |
Composition and process
|
|
US4420632A
(en)
|
1980-04-15 |
1983-12-13 |
The Upjohn Company |
Composition and process
|
|
US4306076A
(en)
|
1980-04-23 |
1981-12-15 |
The Upjohn Company |
Inter-phenylene CBA compounds
|
|
US4349689A
(en)
|
1980-12-22 |
1982-09-14 |
The Upjohn Company |
Methano carbacyclin analogs
|
|
US4379454A
(en)
|
1981-02-17 |
1983-04-12 |
Alza Corporation |
Dosage for coadministering drug and percutaneous absorption enhancer
|
|
DE3333240A1
(de)
|
1983-09-12 |
1985-03-28 |
Schering AG, 1000 Berlin und 4709 Bergkamen |
Mittel zur transdermalen applikation von arzneimittelwirkstoffen
|
|
US4668814A
(en)
|
1984-03-08 |
1987-05-26 |
The Upjohn Company |
Interphenylene carbacyclin derivatives
|
|
US4683330A
(en)
|
1984-03-08 |
1987-07-28 |
The Upjohn Company |
Interphenylene carbacyclin derivatives
|
|
GB8824187D0
(en)
|
1988-10-14 |
1988-11-23 |
Wellcome Found |
Compounds for use in medicine
|
|
GB8814438D0
(en)
|
1988-06-17 |
1988-07-20 |
Wellcome Found |
Compounds for use in medicine
|
|
US5088977A
(en)
|
1988-12-21 |
1992-02-18 |
Drug Delivery Systems Inc. |
Electrical transdermal drug applicator with counteractor and method of drug delivery
|
|
CA2056039A1
(en)
|
1991-01-22 |
1992-07-23 |
Philip L. Fuchs |
Carbacyclin analogs
|
|
US5234690A
(en)
|
1991-08-23 |
1993-08-10 |
Cygnus Therapeutic Systems |
Transdermal drug delivery device using an unfilled microporous membrane to achieve delayed onset
|
|
US5869505A
(en)
|
1993-02-02 |
1999-02-09 |
Keenan; Robert M. |
Nicotine metabolites and nicotine dependence
|
|
US5853751A
(en)
|
1993-06-23 |
1998-12-29 |
Masiz; John J. |
Molecular transdermal transport system
|
|
US5797898A
(en)
|
1996-07-02 |
1998-08-25 |
Massachusetts Institute Of Technology |
Microchip drug delivery devices
|
|
IN184589B
(enExample)
|
1996-10-16 |
2000-09-09 |
Alza Corp |
|
|
KR20020012169A
(ko)
*
|
1999-03-31 |
2002-02-15 |
유나이티드 쎄러퓨틱스 코포레이션 |
프로스타글란딘 화합물, 조성물 및 말초혈관질병 및폐고혈압증의 치료방법
|
|
WO2001052823A2
(en)
|
2000-01-20 |
2001-07-26 |
Noven Pharmaceuticals, Inc. |
Compositions to effect the release profile in the transdermal administration of drugs
|
|
US6242482B1
(en)
|
2000-06-05 |
2001-06-05 |
United Therapeutics Corporation |
Prostaglandin compounds and derivatives thereof, compositions containing the same and method of using the same for the treatment of congestive heart failure
|
|
US6635274B1
(en)
|
2000-10-27 |
2003-10-21 |
Biochemics, Inc. |
Solution-based transdermal drug delivery system
|
|
US6700025B2
(en)
|
2001-01-05 |
2004-03-02 |
United Therapeutics Corporation |
Process for stereoselective synthesis of prostacyclin derivatives
|
|
US20030108512A1
(en)
|
2001-12-10 |
2003-06-12 |
Robert Shorr |
Modified prostaglandin compounds and analogs thereof, compositions containing the same useful for the treatment of cancer
|
|
US8246979B2
(en)
|
2002-07-30 |
2012-08-21 |
Ucb Pharma Gmbh |
Transdermal delivery system for the administration of rotigotine
|
|
EP1628654B2
(en)
|
2003-05-22 |
2019-12-04 |
United Therapeutics Corporation |
Compounds and methods for delivery of prostacyclin analogs
|
|
CA2530407A1
(en)
*
|
2003-07-23 |
2005-02-03 |
The Regents Of The University Of California |
Penetration enhancer combinations for transdermal delivery
|
|
US7375139B2
(en)
|
2003-08-18 |
2008-05-20 |
Aldred Katherine M |
Transdermal method and apparatus
|
|
JP2005120069A
(ja)
|
2003-10-13 |
2005-05-12 |
Anges Mg Inc |
炎症性疾患治療薬
|
|
ATE473736T1
(de)
*
|
2003-12-16 |
2010-07-15 |
United Therapeutics Corp |
Verwendung von treprostinil zur behandlung von ischämischen läsionen
|
|
ATE441418T1
(de)
|
2003-12-16 |
2009-09-15 |
United Therapeutics Corp |
Verwendung von treprostinil zur verbesserung der nierenfunktion
|
|
ATE462427T1
(de)
|
2004-04-12 |
2010-04-15 |
United Therapeutics Corp |
Verwendung von treprostinil zur behandlung von neuropathischen diabetischen fussgeschwüren
|
|
US7537590B2
(en)
|
2004-07-30 |
2009-05-26 |
Microchips, Inc. |
Multi-reservoir device for transdermal drug delivery and sensing
|
|
US20060078604A1
(en)
|
2004-10-08 |
2006-04-13 |
Noven Pharmaceuticals, Inc. |
Transdermal drug delivery device including an occlusive backing
|
|
BRPI0611134A2
(pt)
|
2005-06-03 |
2010-08-17 |
Acrux Dds Pty Ltd |
método e composição para liberação transdérmica de fármaco
|
|
JP5225100B2
(ja)
|
2005-12-20 |
2013-07-03 |
テイコク ファーマ ユーエスエー インコーポレーテッド |
インドールセロトニン受容体作動薬の経皮投与方法及びそれを使用するための経皮組成物
|
|
LT1988910T
(lt)
|
2006-02-28 |
2018-01-10 |
Kodiak Sciences Inc. |
Akriloiloksietilfosforilcholiną turintys polimero konjugatai ir jų gavimo būdas
|
|
US8747897B2
(en)
|
2006-04-27 |
2014-06-10 |
Supernus Pharmaceuticals, Inc. |
Osmotic drug delivery system
|
|
WO2007134292A2
(en)
|
2006-05-15 |
2007-11-22 |
United Therapeutics Corporation |
Treprostinil administration using a metered dose inhaler
|
|
WO2008002929A2
(en)
|
2006-06-26 |
2008-01-03 |
Inverseon, Inc. |
Heterologous cross-sensitization for improved agonist activity
|
|
US20090036465A1
(en)
|
2006-10-18 |
2009-02-05 |
United Therapeutics Corporation |
Combination therapy for pulmonary arterial hypertension
|
|
JP2010518122A
(ja)
|
2007-02-09 |
2010-05-27 |
ユナイテッド セラピューティクス コーポレーション |
間質性肺疾患および喘息のためのトレプロスチニル処置
|
|
EP2170397A1
(en)
|
2007-07-11 |
2010-04-07 |
Lexicon Pharmaceuticals, Inc. |
Methods and compositions for treating pulmonary hypertension and related diseases and disorders
|
|
CN103274926B
(zh)
|
2007-12-17 |
2016-08-10 |
联合治疗公司 |
一种制备Remodulin中的活性成分曲前列素的改良方法
|
|
WO2009152160A1
(en)
|
2008-06-10 |
2009-12-17 |
Gilead Sciences, Inc. |
Inhaled carbaprostacyclin and prostacyclin prodrugs for the treatment of pulmonary arterial hypertension
|
|
WO2009158010A1
(en)
|
2008-06-27 |
2009-12-30 |
Concert Pharmaceuticals, Inc. |
Prostacyclin analogs
|
|
US8809334B2
(en)
|
2008-08-13 |
2014-08-19 |
Actelion Pharmaceuticals Ltd. |
Therapeutic compositions containing macitentan
|
|
RU2011132125A
(ru)
|
2008-12-30 |
2013-02-10 |
Тромбологик Апс |
Способы идентификации критических пациентов с повышенным риском развития органной недостаточности и соединения для их лечения
|
|
WO2010129757A1
(en)
|
2009-05-07 |
2010-11-11 |
United Therapeutics Corporation |
Solid formulations of prostacyclin analogs
|
|
WO2011005505A2
(en)
|
2009-06-22 |
2011-01-13 |
Johnson Matthey Public Limited Company |
Method for the purification of prostaglandins
|
|
ES2451790T3
(es)
|
2009-08-07 |
2014-03-28 |
Scipharm Sàrl |
Composición para el tratamiento de la fibrosis quística
|
|
US9327105B2
(en)
*
|
2010-03-26 |
2016-05-03 |
Itrace Biomedical Inc. |
Active transdermal drug delivery system and the method thereof
|
|
EP4450523A3
(en)
|
2010-04-02 |
2025-03-12 |
Amunix Pharmaceuticals, Inc. |
Binding fusion proteins, binding fusion protein-drug conjugates, xten-drug conjugates and methods of making and using same
|
|
US8557961B2
(en)
|
2010-04-02 |
2013-10-15 |
Amunix Operating Inc. |
Alpha 1-antitrypsin compositions and methods of making and using same
|
|
EP2563369A2
(en)
|
2010-04-29 |
2013-03-06 |
Thrombologic APS |
Methods of treatment of patients at increased risk of development of ischemic events and compounds hereof
|
|
KR101868166B1
(ko)
|
2010-06-03 |
2018-06-15 |
유나이티드 세러퓨틱스 코오포레이션 |
트레프로스티닐의 제조
|
|
WO2012006273A1
(en)
|
2010-07-09 |
2012-01-12 |
United Therapeutics Corporation |
Combination therapies with cox-2 inhibitors and treprostinil
|
|
CA2710726C
(en)
|
2010-07-22 |
2016-02-23 |
Alphora Research Inc. |
Synthesis of treprostinil and intermediates useful therein
|
|
CA2726599C
(en)
|
2010-12-30 |
2017-07-25 |
Alphora Research Inc. |
Process for treprostinil salt preparation
|
|
DK2663313T3
(en)
|
2011-01-13 |
2018-11-26 |
Scipharm S A R L |
PROCEDURE FOR IMPROVING ENGRAFTMENT OF HEMATOPOIETIC STEM CELLS
|
|
WO2012107364A1
(en)
|
2011-02-07 |
2012-08-16 |
Scipharm Sàrl |
Novel composition for the treatment of cystic fibrosis
|
|
ME02598B
(me)
|
2011-02-07 |
2017-06-20 |
Scipharm Sarl |
Nova kompozicija za lečenje cistične fibroze
|
|
EP2699243A1
(en)
|
2011-04-19 |
2014-02-26 |
Rigshospitalet |
Prostacyclin and analogs thereof administered during surgery for prevention and treatment of capillary leakage
|
|
EP2739613A4
(en)
|
2011-08-05 |
2015-01-07 |
Cardero Therapeutics Inc |
flavonoid
|
|
KR101997939B1
(ko)
|
2011-08-12 |
2019-07-08 |
아센디스 파마 에이에스 |
담체-연결된 트레프로스티닐 전구약물
|
|
AU2012296955B2
(en)
|
2011-08-12 |
2016-12-15 |
Ascendis Pharma A/S |
Carrier-linked prodrugs having reversible carboxylic ester linkages
|
|
KR20140082649A
(ko)
|
2011-08-12 |
2014-07-02 |
아센디스 파마 에이에스 |
프로스타사이클린의 서방형 조성물
|
|
US8524939B2
(en)
|
2011-08-24 |
2013-09-03 |
Chirogate International Inc. |
Intermediates for the synthesis of benzindene prostaglandins and preparations thereof
|
|
CN103193627B
(zh)
*
|
2012-01-10 |
2016-04-20 |
上海天伟生物制药有限公司 |
一种前列腺素类似物的晶型及其制备方法和用途
|
|
US9387214B2
(en)
|
2012-01-13 |
2016-07-12 |
United Therapeutics Corporation |
Method of identifying therapies for pulmonary hypertension
|
|
WO2013143548A1
(en)
|
2012-03-30 |
2013-10-03 |
Rigshospitalet |
Compounds capable of modulating/preserving endothelial integrity for use in prevention or treatment of acute traumatic coagulopathy and resuscitated cardiac arrest
|
|
AU2013254756B2
(en)
|
2012-04-25 |
2017-03-30 |
Ascendis Pharma A/S |
Prodrugs of hydroxyl-comprising drugs
|
|
ES2639823T3
(es)
|
2012-06-15 |
2017-10-30 |
Scipharm Sàrl |
Proceso para la preparación de treprostinilo y derivados del mismo
|
|
EP2879682B1
(en)
|
2012-08-01 |
2018-03-21 |
United Therapeutics Corporation |
Treatment of pulmonary arterial hypertension with mesenchymal stem cells
|
|
JP6342414B2
(ja)
|
2012-12-07 |
2018-06-13 |
ケイマン ケミカル カンパニー， インコーポレーテッド |
プロスタサイクリン類似体を合成する方法
|
|
AU2014205557B2
(en)
|
2013-01-09 |
2017-08-10 |
United Therapeutics Corporation |
Treatment of vasculopathy with prostacyclin and mesenchymal stem cells
|
|
US9505737B2
(en)
*
|
2013-01-11 |
2016-11-29 |
Corsair Pharma, Inc. |
Treprostinil derivative compounds and methods of using same
|
|
EP4137127A1
(en)
|
2013-01-11 |
2023-02-22 |
Corsair Pharma, Inc. |
Prodrugs of treprostinil
|
|
CA2904598C
(en)
|
2013-03-15 |
2021-10-05 |
United Therapeutics Corporation |
Salts of treprostinil
|
|
CN105228451B
(zh)
|
2013-03-25 |
2018-03-30 |
联合治疗公司 |
制备具有硫醇连接子和聚乙二醇化形式的前列环素化合物的方法
|
|
US9758465B2
(en)
|
2013-04-30 |
2017-09-12 |
United Therapeutics Corporation |
Controlled release pharmaceutical formulations
|
|
WO2014203278A2
(en)
|
2013-06-19 |
2014-12-24 |
Msn Laboratories Private Limited |
NOVEL PROCESS FOR THE PREPARATION OF (1R,2R,3aS,9aS)-[[2,3,3a,4,9,9a-HEXAHYDRO-2-HYDROXY-1-[(3S)-3-HYDROXYOCTYL]-1H-BENZ[f]INDEN-5-YL]OXY]ACETIC ACID
|
|
US20170049739A1
(en)
|
2013-10-25 |
2017-02-23 |
Insmed Incorporated |
Prostacyclin compounds, compositions and methods of use thereof
|
|
CA2930574A1
(en)
|
2013-11-13 |
2015-05-21 |
Cayman Chemical Company Incorporated |
Amine salts of a prostacyclin analog
|
|
WO2015138423A1
(en)
|
2014-03-11 |
2015-09-17 |
Insmed Incorporated |
Prostacylin compositions and methods for using the same
|
|
EP3828160A1
(en)
|
2014-07-16 |
2021-06-02 |
Corsair Pharma, Inc. |
Treprostinil derivative compounds and methods of using same
|
|
HU231184B1
(hu)
|
2014-10-08 |
2021-07-28 |
CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. |
Treprostinil-nátrium-monohidrát és eljárás ennek előállítására
|
|
JP6866043B2
(ja)
|
2014-11-18 |
2021-04-28 |
インスメッド インコーポレイテッド |
トレプロスチニルプロドラッグおよびトレプロスチニル誘導体プロドラッグの製造方法
|
|
TWI540121B
(zh)
|
2014-12-01 |
2016-07-01 |
臺灣永光化學工業股份有限公司 |
曲前列環素二乙醇胺之合成方法及新穎中間體
|
|
CA2973147A1
(en)
|
2015-01-27 |
2016-08-04 |
Scipharm Sarl |
Composition for the treatment of hepatic veno-occlusive disease
|
|
US20160243064A1
(en)
|
2015-02-21 |
2016-08-25 |
Gavis Pharmaceuticals |
Novel oral pharmaceutical compositions of treprostinil
|
|
WO2016176555A1
(en)
|
2015-04-29 |
2016-11-03 |
Insmed Incorporated |
Prostacyclin compounds, compositions and methods of use thereof
|
|
US9394227B1
(en)
*
|
2015-06-17 |
2016-07-19 |
Corsair Pharma, Inc. |
Treprostinil derivatives and compositions and uses thereof
|
|
US9643911B2
(en)
|
2015-06-17 |
2017-05-09 |
Corsair Pharma, Inc. |
Treprostinil derivatives and compositions and uses thereof
|
|
JP2020500882A
(ja)
|
2016-12-05 |
2020-01-16 |
コルセア ファーマ インコーポレイテッド |
トレプロスチニルおよびその塩の皮膚投与および経皮投与方法
|